Signaling Pathways That Control Apoptosis in Prostate Cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Prostate cancer is a leading cause of cancer death in men globally.
• Current androgen receptor-targeted therapies are effective but often lead to castration-resistant prostate cancer (CRPC).
• Androgen receptor signaling in prostate cancer is increasingly understood to involve non-cell-autonomous mechanisms, particularly paracrine factors from stromal cells.

Purpose of the Study:

• To review recent advances in understanding apoptosis mechanisms in prostate epithelial cells following androgen ablation.
• To highlight the role of BCL-2 family proteins and druggable signaling pathways in prostate cancer apoptosis.
• To summarize ongoing clinical trials for inhibitors targeting anti-apoptotic signaling pathways in CRPC.

Main Methods:

• Literature review of recent studies on prostate cancer apoptosis.
• Focus on androgen ablation effects on prostate epithelial cells.
• Analysis of BCL-2 family proteins and related signaling pathways.

Main Results:

• Androgen receptor signaling does not solely regulate prostate epithelial cell apoptosis and proliferation autonomously.
• Stromal androgen receptor activation induces paracrine factors crucial for prostate epithelial homeostasis.
• BCL-2 family proteins and specific signaling pathways are key regulators of apoptosis in this context.

Conclusions:

• A deeper understanding of apoptosis regulation in prostate epithelial cells is essential for deciphering CRPC mechanisms.
• Identifying paracrine factors and targeted pathways can lead to novel, life-extending therapies for CRPC.
• Targeting anti-apoptotic signaling pathways shows promise in clinical trials for advanced prostate cancer.